These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30408527)

  • 1. Growing synergy of nanodiamonds in neurodegenerative interventions.
    Saraf J; Kalia K; Bhattacharya P; Tekade RK
    Drug Discov Today; 2019 Feb; 24(2):584-594. PubMed ID: 30408527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
    Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
    Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases.
    Zhang Y; Yang H; Wei D; Zhang X; Wang J; Wu X; Chang J
    Exploration (Beijing); 2021 Dec; 1(3):20210115. PubMed ID: 37323688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
    Fatima J; Siddique YH
    CNS Neurol Disord Drug Targets; 2024; 23(10):1217-1233. PubMed ID: 38288843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.
    He M; Zhang HN; Tang ZC; Gao SG
    Neural Plast; 2021; 2021():8884642. PubMed ID: 34054944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
    Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
    Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
    Dailah HG
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease.
    Wang W; Gopal S; Pocock R; Xiao Z
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31888221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase reverse transcriptase and neurodegenerative diseases.
    Yu X; Liu MM; Zheng CY; Liu YT; Wang Z; Wang ZY
    Front Immunol; 2023; 14():1165632. PubMed ID: 37063844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.
    Ahmad K; Baig MH; Mushtaq G; Kamal MA; Greig NH; Choi I
    Curr Alzheimer Res; 2017; 14(11):1190-1197. PubMed ID: 28164765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
    Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain drug delivery systems for neurodegenerative disorders.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2388-402. PubMed ID: 23016644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing for neurodegenerative diseases.
    Shukla H; John D; Banerjee S; Tiwari AK
    Prog Mol Biol Transl Sci; 2024; 207():249-319. PubMed ID: 38942541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review.
    Singh M; Mazumder B
    Pharm Nanotechnol; 2022; 10(1):42-55. PubMed ID: 34951376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
    Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.
    Fan HC; Chi CS; Cheng SN; Lee HF; Tsai JD; Lin SZ; Harn HJ
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytes as targets for drug discovery.
    Gorshkov K; Aguisanda F; Thorne N; Zheng W
    Drug Discov Today; 2018 Mar; 23(3):673-680. PubMed ID: 29317338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.